2m 2m 2m 2m 2m 2m 2m
- $17.5MMarket Cap
- -25.70%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Universe Pharm-A (UPC)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 38
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
- BCTXZBCTX WT
$0.08-0.61%Market CapN/A1-Year Change-92.16%
Statistics
MoreInformation as of 06/02/2026
Company Profile
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Key Executives
- Baochang Liu
- Lin Yang
- Gang Lai
Current Ownership Distribution
- Institutions2.8M (86.84%)
- Insiders426,292 (13.16%)
- Mutual Funds0 (0.00%)
- Other0 (0.00%)